News
Current News
- New paper suggests sFLC assays aid assessment of acute renal failure01 December 2008
- NEW 5th edition Serum Free Light Chain Analysis (plus Hevylite)17 November 2008
- Hematology Meeting Reports of Proceedings of Biennial 2008 Conference03 November 2008
- First myeloma kidney patient recruited onto EuLITE clinical trial09 June 2008
- Biennial 2008 - Serum Free Light Chain Symposium14 May 2008
- New Cystatin C assay for Roche Modular P18 March 2008
- Independent Review discusses Value of Serum Free Light Chain Assays11 February 2008
- Serum FLC ratio can help assess risk in patients with Smouldering Multiple Myeloma24 January 2008
01 December 2008
New paper suggests sFLC assays aid assessment of acute renal failure
A recent BMC Nephrology on-line article concluded:
"The measurement of serum FLCs [free light chains] can be a practical and highly sensitive aid in the identification of myeloma as the underlying pathology in patients with severe renal failure. Using an extended renal failure reference range for the FLC ratio increased the specificity of the assays. The diagnostic accuracy of these assays and their rapid laboratory turn-around time should aid nephrologists in their assessment of acute renal failure."
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Colin A Hutchison et al. BMC Nephrology 2008;9:11 doi: 10.1186/1471-2369-9-11
Download the article here. This is a free access article, please review the copyright statement on the article front page.
More information on Freelite serum free light chain assays and Freelite and renal disease or Contact us.
